Insurers need to focus on improving the efficacy of current products before effective innovation of new products can be obtained says Chris McGloin, president of Airmic, the UK risk and insurance management association.
The rest of this article is locked for subscribers only. Please use your personal login at the link below to continue reading.
If you don't have a personal login, you will need to purchase a subscription to gain access to this article, including all our online content.
Chris McGloin, Airmic, Efficacy, Innovation
